Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
続きを読む
一部表示